|Articles|September 1, 2018
- BioPharm International-09-01-2018
- Volume 31
- Issue 9
BioPharm International, September 2018 Issue (PDF)
Click the title above to open the BioPharm International September 2018 issue in an interactive PDF format.
Advertisement
Articles in this issue
over 7 years ago
FDA Seeks to Enhance Manufacturing of Cell and Gene Therapiesover 7 years ago
Lightweight Actuator for Aseptic Valvesover 7 years ago
Be a Part of the Solutionover 7 years ago
Evaluating the Rewards vs. the Risks of Automationover 7 years ago
Checking Incoming Goodsover 7 years ago
Biopharma Demand Continues to Influence CMO Actionsover 7 years ago
QbD in the Development of ADCs with PBD Dimer Warheadsover 7 years ago
Patenting Antibodies in EuropeNewsletter
Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.
Advertisement
Advertisement
Advertisement
Trending on BioPharm International
1
FDA-Approved WAS Gene Therapy Hits Market in Nonprofit Model
2
Two-Minute Mysteries: BioPharm Stories - Episode 2: The Costly Myth of Noninvasive Glucose Monitoring
3
Developing Next-Gen Cell Lines Using Targeted Integration
4
FAQ: Shifts in FDA Regulations and Strategies in 2025
5
